Osiris Reaches New 52-Week High (OSIR)

NEW YORK ( TheStreet) -- Osiris Therapeutics (Nasdaq: OSIR) hit a new 52-week high Thursday as it is currently trading at $11.65, above its previous 52-week high of $11.58 with 84,014 shares traded as of 9:40 a.m. ET. Average volume has been 256,900 shares over the past 30 days.

Osiris has a market cap of $335.8 million and is part of the health care sector and drugs industry. Shares are up 91% year to date as of the close of trading on Wednesday.

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets. It operates in two segments, Therapeutics and Biosurgery. The company has a P/E ratio of 35.2, below the average drugs industry P/E ratio of 36.5 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Osiris as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and feeble growth in the company's earnings per share. You can view the full Osiris Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Mesoblast Soars on Stem-Cell Treatment Data

Mesoblast Soars on Stem-Cell Treatment Data

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone